Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese

Nature Communications

Volumn 7, Issue , 2016, Pages

  Li, Yuanfeng ^a,b,c   Si, Lanlan ^a,b,c   Zhai, Yun ^a,b,c   Hu, Yanling ^d   Hu, Zhibin ^e   Bei, Jin Xin ^f   Xie, Bobo ^a,b,c   Ren, Qian ^a,b,c   Cao, Pengbo ^a,b,c   Yang, Fei ^a,b,c   Song, Qingfeng ^d   Bao, Zhiyu ^d   Zhang, Haitao ^a,b,c   Han, Yuqing ^a,b,c   Wang, Zhifu ^a,b,c   Chen, Xi ^a,b,c   Xia, Xia ^a,b,c   Yan, Hongbo ^a,b,c   Wang, Rui ^a,b,c   Zhang, Ying ^a,b,c   Gao, Chengming ^a,b,c   Meng, Jinfeng ^a,b,c   Tu, Xinyi ^a,b,c   Liang, Xinqiang ^d   Cui, Ying ^d   Liu, Ying ^g   Wu, Xiaopan ^g   Li, Zhuo ^h   Wang, Huifen ⁱ   Li, Zhaoxia ^j   Hu, Bo ^j   He, Minghui ^k   Gao, Zhibo ^k   Xu, Xiaobing ^l   Ji, Hongzan ^l   Yu, Chaohui ^m   Sun, Yi ⁿ   Xing, Baocai ⁿ   Yang, Xiaobo ^d   Zhang, Haiying ^d   Tan, Aihua ^d   Wu, Chunlei ^d   Jia, Weihua ^f   Li, Shengping ^f   Zeng, Yi Xin ^f   Shen, Hongbing ^e   He, Fuchu ^a,b,c   Mo, Zengnan ^d   Zhang, Hongxing ^a,b,c   Zhou, Gangqiao ^a,b,c   more..

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^b National Engineering Research Center for Protein Drugs   (China)

^c BEIJING INSTITUTE OF LIFEOMICS   (China)

^d GUANGXI MEDICAL UNIVERSITY   (China)

^e NANJING MEDICAL UNIVERSITY   (China)

^f SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^g INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^h CAPITAL MEDICAL UNIVERSITY   (China)

ⁱ BEIJING 302 HOSPITAL   (China)

^j SUN YAT SEN UNIVERSITY   (China)

^k BGI SHENZHEN   (China)

^l NANJING UNIVERSITY   (China)

^m ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

ⁿ PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 29; MESSENGER RNA; VIRUS DNA; VIRUS RNA; CARRIER PROTEIN; INTS10 PROTEIN, HUMAN; IRF3 PROTEIN, HUMAN;

CELLS AND CELL COMPONENTS; GENE EXPRESSION; GENOME; HEPATITIS; IDENTIFICATION KEY; INFECTIOUS DISEASE; PERSISTENCE; PLASMA; STUDY METHOD; VIRAL DISEASE;

ADULT; AGED; ALLELE; ARTICLE; CHINESE; CHROMOSOME 8P; CHROMOSOME IDENTIFICATION; CHROMOSOME REPLICATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HAPLOTYPE MAP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; PERSISTENT INFECTION; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; VIRUS LOAD; VIRUS REPLICATION; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; CELL LINE; CHROMOSOME 8; CHRONIC HEPATITIS B; CYTOLOGY; GENE LOCUS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; LIVER CELL; META ANALYSIS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SEROLOGY; VIROLOGY; YOUNG ADULT;

CHINA;

HEPATITIS B VIRUS;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELL LINE; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; INTERFERON REGULATORY FACTOR-3; LIVER; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROLOGIC TESTS; VIRAL LOAD; VIRUS REPLICATION; YOUNG ADULT;

EID: 84973345849     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11664     Document Type: Article

References (43)

1. Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G. & Ott, J. J. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet 386, 1546-1555 (2015).
2. Chu, C. J. & Lok, A. S. Clinical significance of hepatitis B virus genotypes. Hepatology 35, 1274-1276 (2002).
3. Thursz, M. Genetic susceptibility in chronic viral hepatitis. Antiviral Res. 52, 113-116 (2001).
4. Hann, H. W., Kim, C. Y., London, W. T., Whitford, P. & Blumberg, B. S. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea. Int. J. Cancer 30, 47-51 (1982).
5. Lin, T. M. et al. Hepatitis B virus markers in Chinese twins. Anticancer Res. 9, 737-741 (1989).
6. Kamatani, Y. et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet. 41, 591-595 (2009).
7. Mbarek, H. et al. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum. Mol. Genet. 20, 3884-3892 (2011).
8. Kim, Y. J. et al. A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum. Mol. Genet. 22, 4233-4238 (2013).
9. Hu, Z. et al. New loci associated with chronic hepatitis B virus infection in Han Chinese. Nat. Genet. 45, 1499-1503 (2013).
10. Jiang, D. K. et al. Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B. Hepatology 62, 118-128 (2015).
11. Hohler, T. et al. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin. Exp. Immunol. 111, 579-582 (1998).
12. Yang, X. et al. Genome-wide association study for serum complement C3 and C4 levels in healthy Chinese subjects. PLoS Genet. 8, e1002916 (2012).
13. Zhang, H. et al. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat. Genet. 42, 755-758 (2010).
14. Hu, Z. et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat. Genet. 43, 792-796 (2011).
15. Bei, J. X. et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat. Genet. 42, 599-603 (2010).
16. Hu, L. et al. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 55, 1426-1431 (2012).
17. Ma, J. et al. Association of NKG2D genetic polymorphism with susceptibility to chronic hepatitis B in a Han Chinese population. J. Med. Virol. 82, 1501-1507 (2010).
18. Cheong, J. Y., Shin, H. D., Kim, Y. J. & Cho, S. W. Association of polymorphism in MicroRNA 219-1 with clearance of hepatitis B virus infection. J. Med. Virol. 85, 808-814 (2013).
19. Zheng, X. et al. HIBAG-HLA genotype imputation with attribute bagging. Pharmacogenomics J. 14, 192-200 (2014).
20. Kan, Z. et al. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res. 23, 1422-1433 (2013).
21. Sung, W. K. et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet. 44, 765-769 (2012).
22. Yamamoto, J. et al. DSIF and NELF interact with Integrator to specify the correct post-transcriptional fate of snRNA genes. Nat. Commun. 5, 4263 (2014).
23. Baillat, D. et al. Integrator, a multiprotein mediator of small nuclear RNA processing, associates with the C-terminal repeat of RNA polymerase II. Cell 123, 265-276 (2005).
24. Matera, A. G. & Wang, Z. A day in the life of the spliceosome. Nat. Rev. Mol. Cell Biol. 15, 108-121 (2014).
25. Skaar, J. R. et al. The Integrator complex controls the termination of transcription at diverse classes of gene targets. Cell Res. 25, 288-305 (2015).
26. Stadelmayer, B. et al. Integrator complex regulates NELF-mediated RNA polymerase II pause/release and processivity at coding genes. Nat. Commun. 5, 5531 (2014).
27. Gardini, A. et al. Integrator regulates transcriptional initiation and pause release following activation. Mol. Cell 56, 128-139 (2014).
28. Krupp, M. et al. RNA-Seq Atlas-a reference database for gene expression profiling in normal tissue by next-generation sequencing. Bioinformatics 28, 1184-1185 (2012).
29. Sato, S. et al. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity 42, 123-132 (2014).
30. Lu, H. L. & Liao, F. Melanoma differentiation-associated gene 5 senses hepatitis B virus and activates innate immune signaling to suppress virus replication. J. Immunol. 191, 3264-3276 (2013).
31. Han, Q., Zhang, C., Zhang, J. & Tian, Z. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner. Hepatology 54, 1179-1189 (2011).
32. Bruns, A. M. & Horvath, C. M. Activation of RIG-I-like receptor signal transduction. Crit. Rev. Biochem. Mol. Biol. 47, 194-206 (2012).
33. Jiang, J. & Tang, H. Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein. Protein Cell 1, 1106-1117 (2010).
34. Kumar, M. et al. Hepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferon. J Virol. 85, 987-995 (2011).
35. Wang, X., Li, Y., Mao, A., Li, C. & Tien, P. Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-beta induction by disrupting the VISA-associated complex. Cell. Mol. Immunol. 7, 341-348 (2010).
36. Wei, C. et al. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J. Immunol. 185, 1158-1168 (2010).
37. Yu, S. et al. Hepatitis B virus polymerase inhibits RIG-I-and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J. Gen. Virol. 91, 2080-2090 (2010).
38. Li, Y., Willer, C. J., Ding, J., Scheet, P. & Abecasis, G. R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816-834 (2010).
39. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
40. Li, Y., Willer, C., Sanna, S. & Abecasis, G. Genotype imputation. Annu. Rev. Genomics Hum. Genet. 10, 387-406 (2009).
41. Thursz, M. R. et al. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N. Engl. J. Med. 332, 1065-1069 (1995).
42. Hohler, T. et al. HLA-DRB1∗1301 and ∗1302 protect against chronic hepatitis B. J. Hepatol. 26, 503-507 (1997).
43. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190-2191 (2010).